title: Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells.
abstract: Ectopic overexpression of v-H-Ras protein in NIH 3T3 cells resulted in cellular transformation and an acceleration of G1 progression of these cells. A shortened G1 phase was found to be associated with an increased level of cyclin D1 but not cyclin E protein. Using an antisense blocking method, reduced synthesis of cyclin D1 in v-H-Ras transformants resulted in a slower G1 progression rate of these cells. Although constitutive overexpression of cyclin D1 in NIH 3T3 cells accelerated G1 progression, cells remained untransformed. Furthermore, inhibition of cyclin D1 synthesis greatly impaired the soft-agar cloning efficiency of v-H-Ras transformants. These results suggest that increased expression of cyclin D1 is necessary but not sufficient for the transforming activity of v-H-Ras. Similar effect on cell cycle progression was also observed in Raf-transformed cells. In addition to cyclin D1, cyclin E protein was found to be elevated in Src transformants. This may account for the further shortening of the G1 phase of these cells. Activation of an additional Ras-independent pathway was suggested to be responsible for the further acceleration of the G1 phase in Src transformants.
authors.affiliation: Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, Republic of China.
authors.forename: J J
authors.initials: JJ
authors.lastname: Liu
authors.forename: J R
authors.initials: JR
authors.lastname: Chao
authors.forename: M C
authors.initials: MC
authors.lastname: Jiang
authors.forename: S Y
authors.initials: SY
authors.lastname: Ng
authors.forename: J J
authors.initials: JJ
authors.lastname: Yen
authors.forename: H F
authors.initials: HF
authors.lastname: Yang-Yen
mesh_terms: D016475:3T3 Cells; D000818:Animals; D015152:Blotting, Northern; D002471:Cell Transformation, Neoplastic; D002999:Clone Cells; D019938:Cyclin D1; D016213:Cyclins / Q000096:biosynthesis* / Q000235:genetics; D005434:Flow Cytometry; D016193:G1 Phase / Q000502:physiology; D015151:Immunoblotting; D007399:Interphase / Q000502:physiology*; D051379:Mice; D015688:Oncogene Protein pp60(v-src) / Q000096:biosynthesis / Q000235:genetics; D015513:Oncogene Proteins / Q000096:biosynthesis* / Q000235:genetics; D027384:Oncogene Proteins v-raf; D016283:Proto-Oncogene Proteins p21(ras) / Q000096:biosynthesis* / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D015682:Retroviridae Proteins, Oncogenic / Q000096:biosynthesis / Q000235:genetics; D016196:S Phase / Q000502:physiology; D013997:Time Factors; D014170:Transformation, Genetic
chemical_list: D016213:Cyclins; D015513:Oncogene Proteins; D012333:RNA, Messenger; D015682:Retroviridae Proteins, Oncogenic; D019938:Cyclin D1; D015688:Oncogene Protein pp60(v-src); D027384:Oncogene Proteins v-raf; D016283:Proto-Oncogene Proteins p21(ras)